- Home
- RXO vs CPRX Comparison
RXO vs CPRX Comparison
Compare RXO & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RXO
- CPRX
- Stock Information
- Founded
- RXO 2022
- CPRX 2002
- Country
- RXO United States
- CPRX United States
- Employees
- RXO N/A
- CPRX N/A
- Industry
- RXO
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- RXO
- CPRX Health Care
- Exchange
- RXO Nasdaq
- CPRX Nasdaq
- Market Cap
- RXO 2.9B
- CPRX 2.6B
- IPO Year
- RXO N/A
- CPRX 2006
- Fundamental
- Price
- RXO $16.25
- CPRX $20.46
- Analyst Decision
- RXO Hold
- CPRX Strong Buy
- Analyst Count
- RXO 15
- CPRX 5
- Target Price
- RXO $17.77
- CPRX $33.20
- AVG Volume (30 Days)
- RXO 2.0M
- CPRX 1.5M
- Earning Date
- RXO 08-07-2025
- CPRX 08-06-2025
- Dividend Yield
- RXO N/A
- CPRX N/A
- EPS Growth
- RXO N/A
- CPRX 183.96
- EPS
- RXO N/A
- CPRX 1.65
- Revenue
- RXO $5,559,000,000.00
- CPRX $558,499,000.00
- Revenue This Year
- RXO $31.63
- CPRX $16.51
- Revenue Next Year
- RXO $7.35
- CPRX $9.58
- P/E Ratio
- RXO N/A
- CPRX $12.40
- Revenue Growth
- RXO 46.41
- CPRX 28.55
- 52 Week Low
- RXO $12.19
- CPRX $19.00
- 52 Week High
- RXO $31.98
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- RXO 54.70
- CPRX 46.75
- Support Level
- RXO $15.76
- CPRX $19.83
- Resistance Level
- RXO $17.11
- CPRX $21.82
- Average True Range (ATR)
- RXO 0.75
- CPRX 0.56
- MACD
- RXO 0.18
- CPRX 0.06
- Stochastic Oscillator
- RXO 70.73
- CPRX 37.56
About RXO RXO Inc.
RXO Inc is a brokered transportation platform defined by cutting-edge technology and a nimble, asset-light business model, with the component being core truck brokerage business. Its operations also include three asset-light, brokered transportation services, all of which complement its truck brokerage business: managed transportation, last mile and freight forwarding. The company operates into one reportable segment. The operates within the transportation industry and in the same geography North America.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).